Published in Bone on April 27, 2007
In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials (2008) 3.39
High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A (2011) 1.87
Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther (2008) 1.53
Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater (2008) 1.43
Biomedical applications of chemically-modified silk fibroin. J Mater Chem (2009) 1.17
Nell-1 enhances bone regeneration in a rat critical-sized femoral segmental defect model. Plast Reconstr Surg (2011) 1.11
Review physical and chemical aspects of stabilization of compounds in silk. Biopolymers (2012) 0.98
Elastomeric osteoconductive synthetic scaffolds with acquired osteoinductivity expedite the repair of critical femoral defects in rats. Tissue Eng Part A (2010) 0.98
Silk-based biomaterials for sustained drug delivery. J Control Release (2014) 0.94
Quantifying the 3D macrostructure of tissue scaffolds. J Mater Sci Mater Med (2008) 0.94
Natural and Genetically Engineered Proteins for Tissue Engineering. Prog Polym Sci (2012) 0.87
A silk hydrogel-based delivery system of bone morphogenetic protein for the treatment of large bone defects. J Mech Behav Biomed Mater (2011) 0.87
Remodeling of tissue-engineered bone structures in vivo. Eur J Pharm Biopharm (2013) 0.87
Can rhBMP-2 containing collagen sponges enhance bone repair in ovariectomized rats?: a preliminary study. Clin Orthop Relat Res (2009) 0.85
Cyclic stretch enhances bone morphogenetic protein-2-induced osteoblastic differentiation through the inhibition of Hey1. Int J Mol Med (2015) 0.84
Silk constructs for delivery of musculoskeletal therapeutics. Adv Drug Deliv Rev (2012) 0.84
Tissue-engineered bone constructed in a bioreactor for repairing critical-sized bone defects in sheep. Int Orthop (2014) 0.80
Biomaterial-mediated strategies targeting vascularization for bone repair. Drug Deliv Transl Res (2016) 0.79
A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice. Stem Cell Res Ther (2013) 0.79
Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films. Acta Biomater (2013) 0.78
In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies. Cell Tissue Res (2011) 0.78
Regeneration of rabbit calvarial defects using cells-implanted nano-hydroxyapatite coated silk scaffolds. Biomater Res (2015) 0.77
Biological responses to spider silk-antibiotic fusion protein. J Tissue Eng Regen Med (2011) 0.77
Quantitative characterization of mineralized silk film remodeling during long-term osteoblast-osteoclast co-culture. Biomaterials (2014) 0.77
Cell-tethered ligands modulate bone remodeling by osteoblasts and osteoclasts. Adv Funct Mater (2014) 0.76
Three-dimensionally presented anti-fouling zwitterionic motifs sequester and enable high-efficiency delivery of therapeutic proteins. Acta Biomater (2014) 0.75
Escherichia coli-derived recombinant human bone morphogenetic protein-2 combined with bone marrow-derived mesenchymal stromal cells improves bone regeneration in canine segmental ulnar defects. BMC Vet Res (2016) 0.75
Application of bone growth factors--the potential of different carrier systems. Oral Maxillofac Surg (2010) 0.75
In-vivo evaluation of subcutaneously implanted cell-loaded apatite microcarriers for osteogenic potency. J Mater Sci Mater Med (2017) 0.75
Silk-based biomaterials. Biomaterials (2003) 7.72
Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res (2001) 3.26
Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26
Silk implants for the healing of critical size bone defects. Bone (2005) 2.22
Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A (2004) 1.94
Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A (2006) 1.68
The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. J Bone Joint Surg Am (1984) 1.41
Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40
Mesenchymal stem cells and bone regeneration. Vet Surg (2006) 1.31
Potential applications and delivery strategies for bone morphogenetic proteins. Adv Drug Deliv Rev (2000) 1.28
Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg (2005) 0.93
Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers. Int J Pharm (1999) 0.90
Critically sized osteo-periosteal femoral defects: a dog model. J Invest Surg (1999) 0.88
Asymmetric leaves1 mediates leaf patterning and stem cell function in Arabidopsis. Nature (2001) 4.17
Severe proliferative and necrotizing pneumonia in pigs: A newly recognized disease. Can Vet J (1990) 4.02
Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation. Biochem J (1987) 2.84
Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet (1998) 2.79
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1985) 2.47
The ontogeny of human gyrification. Cereb Cortex (1995) 2.32
Conversion of closed circular DNA molecules to single-nicked molecules by digestion with DNAase I in the presence of ethidium bromide. Biochim Biophys Acta (1975) 2.32
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A (1995) 2.19
The genetic mucopolysaccharidoses. Medicine (Baltimore) (1965) 2.04
A school health education program for children with asthma aged 8-11 years. Health Educ Q (1987) 1.85
Morbidity of laparoscopic surgery for complicated appendicitis: an international study. Surg Endosc (2006) 1.84
Prenatal cocaine exposure is associated with respiratory pattern abnormalities. Am J Dis Child (1989) 1.80
Cellular proteins that associate with the middle and small T antigens of polyomavirus. J Virol (1988) 1.78
Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum (1978) 1.74
Diaphragmatic plication for unilateral diaphragmatic paralysis: a 10-year experience. Ann Thorac Surg (1990) 1.74
Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol (2000) 1.73
Silk fibroin as an organic polymer for controlled drug delivery. J Control Release (2006) 1.71
Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol Cell (2002) 1.69
A survey of osteoarthritis of the knee in the elderly. J Rheumatol (1983) 1.66
Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J Biol Chem (2001) 1.63
Direct mapping of nuclear shell effects in the heaviest elements. Science (2012) 1.63
Loss-of-function mutations of SURF-1 are specifically associated with Leigh syndrome with cytochrome c oxidase deficiency. Ann Neurol (1999) 1.63
Effect of tendon release and delayed repair on the structure of the muscles of the rotator cuff: an experimental study in sheep. J Bone Joint Surg Am (2004) 1.61
Protein translocation into mitochondria: the role of TIM complexes. Trends Cell Biol (2000) 1.57
Mycobacterial cervical lymphadenitis: the histological features of non-tuberculous mycobacterial infection. Histopathology (1999) 1.55
Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J (2010) 1.55
Lesions of the acetabular labrum: accuracy of MR imaging and MR arthrography in detection and staging. Radiology (1996) 1.54
Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol (1997) 1.52
FENS-1 and DFCP1 are FYVE domain-containing proteins with distinct functions in the endosomal and Golgi compartments. J Cell Sci (2001) 1.52
An outbreak of Norwalk virus gastroenteritis associated with eating raw oysters. Implications for maintaining safe oyster beds. JAMA (1995) 1.51
Conformational transitions in model silk peptides. Biophys J (2000) 1.51
Azathioprine in the treatment of systemic lupus erythematosus. A controlled study. Arthritis Rheum (1971) 1.48
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J Struct Biol (1995) 1.47
The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors. AAPS PharmSci (1999) 1.47
Development of clinical criteria for osteoarthritis. J Rheumatol (1987) 1.46
Structural and material approaches to bone tissue engineering in powder-based three-dimensional printing. Acta Biomater (2010) 1.46
Expression pattern of a tobacco lipid transfer protein gene within the shoot apex. Plant J (1992) 1.45
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Control Release (2001) 1.45
Silk based biomaterials to heal critical sized femur defects. Bone (2006) 1.40
Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug Chem (2003) 1.39
Divergent genes for translation initiation factor eIF-4A are coordinately expressed in tobacco. Nucleic Acids Res (1991) 1.39
Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg (1997) 1.39
Nerve growth factor stimulation of the Ras-guanine nucleotide exchange factor and GAP activities. Science (1992) 1.39
Abelson virus-transformed lymphocytes: null cells that modulate H-2. Cell (1977) 1.37
Experiences of student and practicing physical therapists with inappropriate patient sexual behavior. Phys Ther (1993) 1.37
In vivo behavior of three different injectable hydraulic calcium phosphate cements. Biomaterials (2003) 1.37
A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr Biol (1995) 1.35
NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis. J Cell Biol (1997) 1.30
Expression of polyoma early gene products in E. coli. Nucleic Acids Res (1985) 1.29
Effect of scaffold design on bone morphology in vitro. Tissue Eng (2006) 1.28
Herpes simplex virus type 2 inhibition of Fas ligand expression. J Virol (1996) 1.26
Visualization of ribosomal ribonucleic acid synthesis in a ribonuclease III-Deficient strain of Escherichia coli. J Bacteriol (1977) 1.25
Characterization of middle T antigen expressed by using an adenovirus expression system. J Virol (1987) 1.25
Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther (2004) 1.24
Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets. J Biol Chem (1999) 1.23
Evidence for P-N bond scission in phosphoroamidate nerve agent adducts of human acetylcholinesterase. Biochemistry (2000) 1.21
Experimental acute subdural hematoma in infant piglets. Pediatr Neurosurg (1996) 1.20
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther (2006) 1.18
Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. Proc Natl Acad Sci U S A (1996) 1.18
Evidence for diet effects on the composition of silk proteins produced by spiders. Mol Biol Evol (2000) 1.16
Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. J Control Release (1999) 1.16
Purchasing a cycle helmet: are retailers providing adequate advice? Inj Prev (1996) 1.15
Fetal wastage in patients with rheumatoid arthritis. J Rheumatol (1986) 1.15
Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol (1993) 1.15
Histomorphology and bone morphometry of the bone marrow edema syndrome of the hip. Clin Orthop Relat Res (1997) 1.15
Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cell Mater (2009) 1.15
Bioreactor cultivation of osteochondral grafts. Orthod Craniofac Res (2005) 1.14
Classification of the mucopolysaccharidoses based on the pattern of mucopolysacchariduria. Am J Med (1969) 1.14
On the possibilities of hard X-ray imaging with high spatio-temporal resolution using polychromatic synchrotron radiation. J Xray Sci Technol (2010) 1.14
Treatment of lateral epicondylitis using skin-derived tenocyte-like cells. Br J Sports Med (2009) 1.14
Nitrate reductase as a product-inducible enzyme. Eur J Biochem (1974) 1.11
Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. Biochemistry (1994) 1.10
Interface effects on mechanical properties of particle-reinforced composites. Dent Mater (2004) 1.10
Porous silk scaffolds can be used for tissue engineering annulus fibrosus. Eur Spine J (2007) 1.09
Genetic and structural characterization of the human mitochondrial inner membrane translocase. J Mol Biol (1999) 1.08
Purification and characterization of recombinant spider silk expressed in Escherichia coli. Appl Microbiol Biotechnol (1998) 1.08
Development and field testing of protocols for the management of pediatric telephone calls: protocols for pediatric telephone calls. Pediatrics (1979) 1.08
Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J Clin Oncol (2001) 1.07
Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J Neurosci (1999) 1.07
Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther (2007) 1.07
Bombyx mori silk fibroin liquid crystallinity and crystallization at aqueous fibroin-organic solvent interfaces. Int J Biol Macromol (1999) 1.07
The Trypanosoma cruzi ribosomal P protein family: classification and antigenicity. Parasitol Today (1993) 1.06
A comparison of the composition of silk proteins produced by spiders and insects. Int J Biol Macromol (1999) 1.05
Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required for neuronal survival. J Neurosci (1999) 1.05
Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci U S A (1996) 1.05
Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology (1997) 1.04
Submaximal responses in calcium-triggered exocytosis are explained by differences in the calcium sensitivity of individual secretory vesicles. J Gen Physiol (1998) 1.04
Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J Immunol (1998) 1.03
A systematic mutation screen of 10 nuclear and 25 mitochondrial candidate genes in 21 patients with cytochrome c oxidase (COX) deficiency shows tRNA(Ser)(UCN) mutations in a subgroup with syndromal encephalopathy. J Med Genet (1998) 1.03
Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. J Inherit Metab Dis (2002) 1.03
Ex vivo adenoviral transfer of bone morphogenetic protein 12 (BMP-12) cDNA improves Achilles tendon healing in a rat model. Gene Ther (2008) 1.03